GBIO
Price
$6.34
Change
+$0.20 (+3.26%)
Updated
Oct 3 closing price
Capitalization
41.36M
32 days until earnings call
GLMD
Price
$1.57
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
Capitalization
8.6M
37 days until earnings call
Interact to see
Advertisement

GBIO vs GLMD

Header iconGBIO vs GLMD Comparison
Open Charts GBIO vs GLMDBanner chart's image
Generation Bio
Price$6.34
Change+$0.20 (+3.26%)
Volume$36.33K
Capitalization41.36M
Galmed Pharmaceuticals
Price$1.57
Change-$0.00 (-0.00%)
Volume$64.52K
Capitalization8.6M
GBIO vs GLMD Comparison Chart in %
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. GLMD commentary
Oct 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a StrongBuy and GLMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 04, 2025
Stock price -- (GBIO: $6.34 vs. GLMD: $1.57)
Brand notoriety: GBIO and GLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 10% vs. GLMD: 41%
Market capitalization -- GBIO: $41.36M vs. GLMD: $8.6M
GBIO [@Biotechnology] is valued at $41.36M. GLMD’s [@Biotechnology] market capitalization is $8.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileGLMD’s FA Score has 1 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • GLMD’s FA Score: 1 green, 4 red.
According to our system of comparison, GLMD is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 3 TA indicator(s) are bullish while GLMD’s TA Score has 5 bullish TA indicator(s).

  • GBIO’s TA Score: 3 bullish, 4 bearish.
  • GLMD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLMD is a better buy in the short-term than GBIO.

Price Growth

GBIO (@Biotechnology) experienced а +5.67% price change this week, while GLMD (@Biotechnology) price change was +12.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

GBIO is expected to report earnings on Nov 05, 2025.

GLMD is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GBIO($41.4M) has a higher market cap than GLMD($8.6M). GBIO YTD gains are higher at: -40.189 vs. GLMD (-50.784). GLMD has higher annual earnings (EBITDA): -7.03M vs. GBIO (-69.92M). GBIO has more cash in the bank: 141M vs. GLMD (20.5M). GLMD has less debt than GBIO: GLMD (41K) vs GBIO (85.3M). GBIO has higher revenues than GLMD: GBIO (21.2M) vs GLMD (0).
GBIOGLMDGBIO / GLMD
Capitalization41.4M8.6M481%
EBITDA-69.92M-7.03M995%
Gain YTD-40.189-50.78479%
P/E RatioN/A0.02-
Revenue21.2M0-
Total Cash141M20.5M688%
Total Debt85.3M41K208,049%
FUNDAMENTALS RATINGS
GLMD: Fundamental Ratings
GLMD
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
34

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOGLMD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 20 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZGN10.370.23
+2.27%
Ermenegildo Zegna NV
LUCD1.040.02
+1.96%
Lucid Diagnostics
ELWS2.68N/A
N/A
Earlyworks Co Ltd.
ULH21.43-0.24
-1.11%
Universal Logistics Holdings
U37.89-1.21
-3.09%
Unity Software

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
N/A
XBIO - GLMD
88%
Closely correlated
-0.90%
JSPR - GLMD
31%
Poorly correlated
+2.89%
GBIO - GLMD
29%
Poorly correlated
+3.26%
CDTX - GLMD
28%
Poorly correlated
+3.54%
CRVS - GLMD
28%
Poorly correlated
+2.13%
More